Forum.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 3, p. 183, doi. 10.1007/s40290-015-0101-y
- Publication type:
- Article
Works matching IS 11782595 AND DT 2015 AND VI 29 AND IP 3
Results: 7
1
2
Incorporation of Abuse Potential Assessment into the Development of New Prescription Drugs.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 3, p. 141, doi. 10.1007/s40290-015-0095-5
- By:
- Publication type:
- Article
3
Nanoparticle-Mediated Delivery of Therapeutic Drugs.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 3, p. 155, doi. 10.1007/s40290-015-0096-4
- By:
- Publication type:
- Article
4
Alignment of Competencies to Address Inefficiencies in Medicines Development and Clinical Research: Need for Inter-Professional Education.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 3, p. 131, doi. 10.1007/s40290-015-0097-3
- By:
- Publication type:
- Article
5
An Investigation of Physicians' Perception of Pharmaceutical Trade Names in Jordan's Private Sector Using Real-World and Simulated Approaches.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 3, p. 169, doi. 10.1007/s40290-015-0098-2
- By:
- Publication type:
- Article
6
Major Pharmaceutical Conferences and Courses.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 3, p. 193, doi. 10.1007/s40290-015-0099-1
- Publication type:
- Article
7
Drugs in Clinical Development for Pulmonary Hypertension: Summary and Table.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 3, p. 179, doi. 10.1007/s40290-015-0100-z
- Publication type:
- Article